Roivant Sciences Ltd. Common Shares vs Veeva Systems — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B), while Veeva Systems trades at $285.41 (market cap $46.12B). The key difference: Veeva Systems is the larger of the two by market cap, and Veeva Systems is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Veeva Systems for 5 Days on average.
| ROIV | VEEV | |
|---|---|---|
Market Cap | $24.72B | $46.12B |
Volume | 6,279,442 | 921,537 |
Sector | Health | Technology |
52-Week High | $41.81 | $299.10 |
52-Week Low | $16.04 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $20.99B | $39.03B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →